Why Argenx Organizes Every Team Like A Startup

2026-04-30 · Source: MIT Sloan Management Review · Field: Business & Management — Corporate Strategy & Leadership, Operations & Process Management, Project & Product Management · Depth: Fundamental Awareness, quick

Summary

The organizational structure described centers on "indication teams," which are cross-functional units formed around specific disease diagnoses, such as lupus. Each team's core purpose is to maximize value for stakeholders related to that indication. These teams are composed of diverse capabilities, including scientists, doctors, marketing personnel, and finance representatives, mirroring the structure of a small biotech company. The broader organizational procedures and processes are designed to empower these indication teams to operate autonomously and effectively, enabling them to achieve significant impact within their specific disease areas.

Key takeaway

For executives considering organizational restructuring, adopting an "indication team" model can significantly enhance focus and accountability. By structuring teams around specific outcomes or customer needs, you empower them with the autonomy and diverse expertise required to operate efficiently, much like a focused startup. This approach can drive greater value creation and impact within targeted areas.

Key insights

Organizing teams by disease indication fosters purpose-driven, cross-functional collaboration akin to a small biotech.

Principles

• Organize teams around a clear, stakeholder-meaningful outcome.
• Empower cross-functional teams with diverse capabilities.

Method

Structure teams around specific disease indications, integrating all necessary capabilities (science, medical, marketing, finance) to operate as a self-contained unit focused on maximizing value for that indication.

In practice

• Form teams around specific product lines or customer segments.
• Integrate all required expertise into dedicated project teams.

Topics

• Indication Teams
• Organizational Structure
• Biotech Model
• Cross-functional Teams
• Stakeholder Value

Best for: Executive, Consultant, Operations Professional

Related on AIssential

• Leaders at All Levels: How Argenx Scaled to $4 Billion Without Bureaucracy — Empowering small, cross-functional teams focused on patient outcomes drives innovation and growth, avoiding bureaucracy.
• Organizing productive platform teams — Organizational structure dictates platform design; align teams to desired architecture, not existing complexity.
• Why I Stopped Giving My Team Answers #inspiredleadership #leadershiplessons — Empower teams to make decisions by fostering autonomy and providing support, not direct answers.
• Creating Impactful Teams through Diversity Using Session 0 — Diversity enhances team impact but requires intentional communication strategies to overcome inherent challenges.
• Hybrid Squads Model for Enterprise Product Teams — Balance enterprise stability with execution agility by separating team ownership from temporary project-based capacity allocation.
• The Anatomy of a Founder Cell — The success of high-output "Founder Cells" stems from a specific, non-conventional organizational structure, not merely individual talent.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by MIT Sloan Management Review.